| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Daniel Ansong, Alex Osei Akoto, Delaena Ocloo, Kwaku Ohene-Frempon. Sickle cell disease: management options and challenges in developing countries. Mediterranean journal of hematology and infectious diseases. vol 5. issue 1. 2013-12-23. PMID:24363877. |
common and important morbidities associated with scd are vaso-occlusive episodes, infections, acute chest syndrome (acs), stroke and hip necrosis. |
2013-12-23 |
2023-08-12 |
Not clear |
| I A Lagunju, B J Brown, O O Sodeind. Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal. Pediatric blood & cancer. vol 60. issue 12. 2013-11-26. PMID:23956197. |
chronic blood transfusion (cbt) diminishes the risk of primary and secondary stroke in sickle cell disease (scd). |
2013-11-26 |
2023-08-12 |
Not clear |
| Iris D Buchanan, Anne James-Herry, Ifeyinwa Osunkw. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease. Journal of pediatric hematology/oncology. vol 35. issue 7. 2013-11-22. PMID:23211694. |
transcranial doppler (tcd) ultrasonography is an established screening tool for detecting children with scd at highest risk for stroke by measuring the flow velocity in the large intracranial vessels. |
2013-11-22 |
2023-08-12 |
Not clear |
| Hui Wang, Wei Luo, Jintao Wang, Chiao Guo, Stephanie L Wolffe, Julia Wang, Eddy B Sun, Kori N Bradley, Andrew D Campbell, Daniel T Eitzma. Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease. British journal of haematology. vol 162. issue 1. 2013-08-22. PMID:23590132. |
sickle cell disease (scd) is associated with vascular complications including premature stroke. |
2013-08-22 |
2023-08-12 |
mouse |
| Sheila Razdan, John J Strouse, Rakhi Naik, Sophie Lanzkron, Victor Urrutia, Jon R Resar, Linda M S Resa. Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature. Case reports in hematology. vol 2013. 2013-08-19. PMID:23956892. |
intracardiac shunting via a patent foramen ovale (pfo) is associated with cryptogenic stroke in individuals without scd. |
2013-08-19 |
2023-08-12 |
Not clear |
| Sheila Razdan, John J Strouse, Rakhi Naik, Sophie Lanzkron, Victor Urrutia, Jon R Resar, Linda M S Resa. Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature. Case reports in hematology. vol 2013. 2013-08-19. PMID:23956892. |
recent evidence suggests that pfos are associated with stroke in children with scd, although the role of pfos in adults with stroke and scd is unknown. |
2013-08-19 |
2023-08-12 |
Not clear |
| Sheila Razdan, John J Strouse, Rakhi Naik, Sophie Lanzkron, Victor Urrutia, Jon R Resar, Linda M S Resa. Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature. Case reports in hematology. vol 2013. 2013-08-19. PMID:23956892. |
we review the literature on pfos and stroke in scd. |
2013-08-19 |
2023-08-12 |
Not clear |
| Sheila Razdan, John J Strouse, Rakhi Naik, Sophie Lanzkron, Victor Urrutia, Jon R Resar, Linda M S Resa. Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature. Case reports in hematology. vol 2013. 2013-08-19. PMID:23956892. |
our cases and the literature review illustrate the dire need for further research to evaluate pfo as a potential risk factor for stroke in adults with scd. |
2013-08-19 |
2023-08-12 |
Not clear |
| Mohammad Talaei, Nizal Sarrafzadegan, Masoumeh Sadeghi, Shahram Oveisgharan, Tom Marshall, G Neil Thomas, Rokhsareh Iranipou. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Archives of Iranian medicine. vol 16. issue 3. 2013-08-09. PMID:23432164. |
accurate estimates of the incidence of cardiovascular diseases (cvd) comprising of acute myocardial infarction (ami), unstable angina pectoris (uap), sudden cardiac death (scd), and stroke are very important for public health. |
2013-08-09 |
2023-08-12 |
Not clear |
| Timothy L McCavit, Lei Xuan, Song Zhang, Glenn Flores, Charles T Quin. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. Pediatric blood & cancer. vol 60. issue 5. 2013-05-21. PMID:23151905. |
the success of primary stroke prevention for children with sickle cell disease (scd) throughout the united states is unknown. |
2013-05-21 |
2023-08-12 |
Not clear |
| Timothy L McCavit, Lei Xuan, Song Zhang, Glenn Flores, Charles T Quin. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. Pediatric blood & cancer. vol 60. issue 5. 2013-05-21. PMID:23151905. |
therefore, we aimed to generate national incidence rates of hospitalization for stroke in children with sickle cell disease (scd) before and after publication of the stroke prevention trial in sickle cell anemia (stop trial) in 1998. |
2013-05-21 |
2023-08-12 |
Not clear |
| Alexander M Gorbach, Hans C Ackerman, Wei-Min Liu, Joseph M Meyer, Patricia L Littel, Catherine Seamon, Eleni Footman, Amy Chi, Suzana Zorca, Megan L Krajewski, Michael J Cuttica, Roberto F Machado, Richard O Cannon, Gregory J Kat. Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease. Microvascular research. vol 84. issue 3. 2013-04-26. PMID:22784510. |
vascular dysfunction is an important pathophysiologic manifestation of sickle cell disease (scd), a condition that increases risk of pulmonary hypertension and stroke. |
2013-04-26 |
2023-08-12 |
human |
| M G Cherry, J Greenhalgh, L Osipenko, M Venkatachalam, A Boland, Y Dundar, K Marsh, R Dickson, D C Ree. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation. Health technology assessment (Winchester, England). vol 16. issue 43. 2013-04-09. PMID:23140544. |
for children with scd, the risk of stroke is estimated to be up to 250 times higher than in the general childhood population. |
2013-04-09 |
2023-08-12 |
Not clear |
| M G Cherry, J Greenhalgh, L Osipenko, M Venkatachalam, A Boland, Y Dundar, K Marsh, R Dickson, D C Ree. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation. Health technology assessment (Winchester, England). vol 16. issue 43. 2013-04-09. PMID:23140544. |
no reviews have yet assessed the clinical effectiveness and cost effectiveness of primary stroke prevention strategies in children with scd identified to be at high risk of stroke using tcd ultrasonography. |
2013-04-09 |
2023-08-12 |
Not clear |
| I A Lagunju, B J Brow. Adverse neurological outcomes in Nigerian children with sickle cell disease. International journal of hematology. vol 96. issue 6. 2013-03-21. PMID:23129067. |
stroke represents a major underlying cause of symptomatic epilepsy in scd. |
2013-03-21 |
2023-08-12 |
Not clear |
| I A Lagunju, B J Brow. Adverse neurological outcomes in Nigerian children with sickle cell disease. International journal of hematology. vol 96. issue 6. 2013-03-21. PMID:23129067. |
institution of primary preventive measures for stroke in scd will significantly reduce the burden of stroke and epilepsy associated with scd in nigeria. |
2013-03-21 |
2023-08-12 |
Not clear |
| Arunodaya R Gujjar, Mathew Zacharia, Salam Al-Kindi, Ranjan William, Zakiya Al Lamki, Yasser Wali, Wafa Bashir, Rajeev Jain, Abdullah Al-Asmi, Anil Pathar. Transcranial Doppler ultrasonography in sickle cell disease: a study in Omani patients. Journal of pediatric hematology/oncology. vol 35. issue 1. 2013-02-21. PMID:23249960. |
thirty-three of 59 patients (56%) with scd had neurological symptoms including stroke--12 (20%) and epilepsy--7. |
2013-02-21 |
2023-08-12 |
Not clear |
| Michael R DeBaun, Joseph Telfai. Transition and sickle cell disease. Pediatrics. vol 130. issue 5. 2013-01-07. PMID:23027174. |
these challenges include, but are not limited to, a higher proportion of scd adolescents receiving public health insurance when compared with any other pediatric genetic or chronic diseases; the high proportion of overt strokes or silent cerebral infarcts (~30%) affecting cognition; risk of low high school graduation; and a high rate of comorbid disease, including asthma. |
2013-01-07 |
2023-08-12 |
Not clear |
| Florian Doepp, Christian Kebelmann-Betzing, Anatol Kivi, Stephan J Schreibe. Stenosis or hyperperfusion in sickle cell disease--ultrasound assessment of cerebral blood flow volume. Ultrasound in medicine & biology. vol 38. issue 8. 2012-11-28. PMID:22698503. |
increased blood flow velocity (bfv) in basal cerebral arteries measured by transcranial color-coded sonography (tccs) is a stroke risk factor in sickle cell disease (scd). |
2012-11-28 |
2023-08-12 |
Not clear |
| D O Roberts, B Covert, T Lindsey, V Edwards, L McLaughlin, J Theus, R J Wray, K Jupka, D Baker, M Robbins, M R DeBau. Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion. Immunohematology. vol 28. issue 1. 2012-10-05. PMID:22646143. |
in children with sickle cell disease (scd), primary and secondary prevention of strokes require indefinite regular blood transfusion therapy. |
2012-10-05 |
2023-08-12 |
Not clear |